Jamra primary scholl for children affected by HIV/AIDS, drugs or poverty, Senegal (c) Nell Freeman/Alliance Participants in the Photovioce project, Ecuador © Marcela Nievas for the Alliance
  • Home > News > Barriers to PMTCT in Sub-Saharan Africa

Barriers to PMTCT in Sub-Saharan Africa

24
JUL
2013

Nell Freeman for the Alliance

Our latest peer reviewed publication addressing the uptake of anti-retroviral drugs for prevention of mother-to-child transmission of HIV in sub-Saharan Africa, has just been published in the Journal of the International AIDS Society.

The article set out to investigate and synthesize reasons for low access, initiation and adherence to antiretroviral drugs by mothers and exposed babies for prevention of mother-to-child transmission (PMTCT) of HIV in sub-Saharan Africa.

The research showed that the provision of anti-retroviral drugs to an HIV-infected mother and her newborn baby is a critical component of prevention of mother-to-child transmission (PMTCT) of HIV, and is key to changing the trajectory  of HIV in sub-Saharan Africa, and that the uptake of anti-retroviral drugs for PMTCT remains unacceptably  low in many countries across sub-Saharan Africa.

The article goes on to discuss the main challenges faced by HIV-infected mothers and health providers in accessing or delivering anti-retroviral drugs for PMTCT and sets out key recommendations for policy makers, community-based organisations implementing PMTCT programmes, health facilities and academic researchers.

The paper was co-authored by Gitau Mburu, Senior Advisor on health systems and services and Kate Iorpenda, Senior Advisor on Children and Impact Mitigation, along with colleagues from the London School of Hygiene and Tropical Medicine.

Download the full article here.